(Natural News) It apparently isn’t enough for the pharmaceutical cartels to hold a total monopoly on all things medicine. Emerging pharmaceutical research is now trying to embed QR codes inside drug pills that are capable of tracking whether or not people take their prescriptions – which means billions of dollars in new profits for drug companies.
They’re giving it more palatable terms like “personalized” medicine – a supposed move away from the mass production model of drug production that send thousands of generic white, blue, and red pills down an assembly line and into nondescript bottles. But the infusion of barcodes into pharma drugs means more power and control for the legal drug lords.
Researchers from the University of Copenhagen in Denmark have been doing much of the dirty work on this front. In conjunction with a team of researchers from Åbo Akademi University in Finland, edible QR material designed for injection into pharmaceuticals is already in the works, and according to those involved with its manufacture, it’ll have the capacity to store all sorts of data.
“Simply doing a quick scan, you can get all the information about the pharmaceutical product,” stated Natalja Genina, an assistant professor in Åbo Akademi University’s Department of Pharmacy. “In that sense it can potentially reduce cases of wrong medication and fake medicine.”
“This technology is promising, because the medical drug can be dosed exactly the way you want it to. This gives an opportunity to tailor the medication according to the patient getting it.”
|Discover how to prevent and reverse heart disease (and other cardio related events) with this free ebook: Written by popular Natural News writer Vicki Batt, this book includes everything you need to know about preventing heart disease, reversing hypertension, and nurturing your cardiac health without medication. Learn More.|
Their hope is that one day it might be possible to print such codes on regular printers, making it easy to apply to the edible material, which would still have to be produced in advance. But the two products could still be easily conjoined, allowing for all sorts of customized applications, depending on the need.
“If we are successful with applying this production method to relatively simple printers, then it can enable the innovative production of personalized medicine and rethinking of the whole supply chain,” added professor Jukka Rantanen, also from the Department of Pharmacy.
Edible QR codes will allow for more monopolistic control of the pill market by Big Pharma
Besides personalization, the technology also stands to allow drugs to become more traceable. So-called drug “fraud” is something that would be a lot tougher if individual drug pills came with their own stamp of authenticity, so to speak, that could be scanned and verified that it actually came from its manufacturer.
Counterfeit drugs, according to Smithsonian Magazine, are a $75 billion per year market that grows larger year after year. Some of these counterfeits contain the wrong ingredient, while others contain no active ingredients at all.
So the benefit of edible QR technology is that, if each pill was properly “marked,” it would make it more difficult for fake pills to saturate the market. This could also potentially reduce the likelihood that drug users end up being harmed or killed by taking counterfeit drugs – or at least this is what advocates of QR technology claim.
What they don’t typically mention is the fact that tracking drug pills in this way also gives powerful drug corporations the upper hand in further controlling the market for FDA-approved medicine. Further, the technology is already beginning to make its way into other consumer products as well, including paychecks, identification cards, and even other food products as an added layer of “security.”
It’s all part of the “smart” agenda to trace and track everything that humans put inside or on their bodies as a form of social control. We’ve been warning about it for years, and it looks like it’s finally arrived.
Read Medicine.news for more coverage of medical technology.
Sources for this article include: